Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2017

Open Access 01-12-2017 | Review

The association between diabetes and dermal microvascular dysfunction non-invasively assessed by laser Doppler with local thermal hyperemia: a systematic review with meta-analysis

Authors: Dagmar Fuchs, Pepijn P. Dupon, Laura A. Schaap, Richard Draijer

Published in: Cardiovascular Diabetology | Issue 1/2017

Login to get access

Abstract

Background/Introduction

Diabetes and cardiovascular disease develop in concert with metabolic abnormalities mirroring and causing changes in the vasculature, particularly the microcirculation. The microcirculation can be affected in different parts of the body of which the skin is the most easily accessible tissue.

Purpose

The association between diabetes and dermal microvascular dysfunction has been investigated in observational studies. However, the strength of the association is unknown. Therefore we conducted a systematic review with meta-analysis on the association between diabetes and dermal microvascular dysfunction as assessed by laser Doppler/laser speckle contrast imaging with local thermal hyperaemia as non-invasive indicator of microvascular functionality.

Methods

PubMed and Ovid were  systematically searched for eligible studies through March 2015. During the first selection, studies were included if they were performed in humans and were related to diabetes or glucose metabolism disorders and to dermal microcirculation. During the second step we selected studies based on the measurement technique, measurement location (arm or leg) and the inclusion of a healthy control group. A random effects model was used with the standardised mean difference as outcome measure. Calculations and imputation of data were done according to the Cochrane Handbook.

Results

Of the 1445 studies found in the first search, thirteen cross-sectional studies were included in the meta-analysis, comprising a total of 857 subjects. Resting blood flow was similar between healthy control subjects and diabetes patients. In contrast, the microvascular response to local skin heating was reduced in diabetic patients compared to healthy control subjects [pooled effect of −0.78 standardised mean difference (95% CI −1.06, −0.51)]. This effect is considered large according to Cohen’s effect size definition. The variability in effect size was high (heterogeneity 69%, p < 0.0001). However, subgroup analysis revealed no difference between the type and duration of diabetes and other health related factors, indicating that diabetes per se causes the microvascular dysfunction.

Conclusion

Our meta-analysis shows that diabetes is associated with a large reduction of dermal microvascular function in diabetic patients. The local thermal hyperaemia methodology may become a valuable non-invasive tool for diagnosis and assessing progress of diabetes-related microvascular complications, but standardisation of the technique and quality of study conduct is urgently required.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tryggestad JB, Willi SM. Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial. J Diabetes Complications. 2015;29:307–12.CrossRefPubMed Tryggestad JB, Willi SM. Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial. J Diabetes Complications. 2015;29:307–12.CrossRefPubMed
2.
go back to reference Paneni F, Costantino S, Cosentino F. Insulin resistance, diabetes, and cardiovascular risk. Curr Atheroscler Rep. 2014;16:419.CrossRefPubMed Paneni F, Costantino S, Cosentino F. Insulin resistance, diabetes, and cardiovascular risk. Curr Atheroscler Rep. 2014;16:419.CrossRefPubMed
3.
go back to reference Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34:2436–43.CrossRefPubMedPubMedCentral Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34:2436–43.CrossRefPubMedPubMedCentral
4.
go back to reference Tousoulis D, Kampoli AM, Stefanadis C. Diabetes mellitus and vascular endothelial dysfunction: current perspectives. Curr Vasc Pharmacol. 2012;10:19–32.CrossRefPubMed Tousoulis D, Kampoli AM, Stefanadis C. Diabetes mellitus and vascular endothelial dysfunction: current perspectives. Curr Vasc Pharmacol. 2012;10:19–32.CrossRefPubMed
5.
go back to reference Tousoulis D, Kampoli AM, Papageorgiou N, Papaoikonomou S, Antoniades C, Stefanadis C. The impact of diabetes mellitus on coronary artery disease: new therapeutic approaches. Curr Pharm Des. 2009;15:2037–48.CrossRefPubMed Tousoulis D, Kampoli AM, Papageorgiou N, Papaoikonomou S, Antoniades C, Stefanadis C. The impact of diabetes mellitus on coronary artery disease: new therapeutic approaches. Curr Pharm Des. 2009;15:2037–48.CrossRefPubMed
6.
go back to reference Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J. 2013;34:2444–52.CrossRefPubMed Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J. 2013;34:2444–52.CrossRefPubMed
9.
go back to reference Vinik AI, Nevoret ML, Casellini C, Parson H. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42:747–87.CrossRefPubMed Vinik AI, Nevoret ML, Casellini C, Parson H. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42:747–87.CrossRefPubMed
10.
go back to reference Morgan AJ, Schwartz RA. Diabetic dermopathy: a subtle sign with grave implications. J Am Acad Dermatol. 2008;58:447–51.CrossRefPubMed Morgan AJ, Schwartz RA. Diabetic dermopathy: a subtle sign with grave implications. J Am Acad Dermatol. 2008;58:447–51.CrossRefPubMed
11.
go back to reference Arya AK, Tripathi R, Kumar S, Tripathi K. Recent advances on the association of apoptosis in chronic non healing diabetic wound. World J Diabetes. 2014;5:756–62.CrossRefPubMedPubMedCentral Arya AK, Tripathi R, Kumar S, Tripathi K. Recent advances on the association of apoptosis in chronic non healing diabetic wound. World J Diabetes. 2014;5:756–62.CrossRefPubMedPubMedCentral
12.
go back to reference Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999;48:1856–62.CrossRefPubMed Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999;48:1856–62.CrossRefPubMed
13.
go back to reference Thoresen M, Walloe L. Skin blood flow in humans as a function of environmental temperature measured by ultrasound. Acta Physiol Scand. 1980;109:333–41.CrossRefPubMed Thoresen M, Walloe L. Skin blood flow in humans as a function of environmental temperature measured by ultrasound. Acta Physiol Scand. 1980;109:333–41.CrossRefPubMed
14.
go back to reference Vanggaard L, Kuklane K, Holmer I, Smolander J. Thermal responses to whole-body cooling in air with special reference to arteriovenous anastomoses in fingers. Clin Physiol Funct Imaging. 2012;32:463–9.CrossRefPubMed Vanggaard L, Kuklane K, Holmer I, Smolander J. Thermal responses to whole-body cooling in air with special reference to arteriovenous anastomoses in fingers. Clin Physiol Funct Imaging. 2012;32:463–9.CrossRefPubMed
15.
go back to reference Berardesca E, Leveque JL, Masson P. EEMCO guidance for the measurement of skin microcirculation. Skin Pharmacol Appl Skin Physiol. 2002;15:442–56.CrossRefPubMed Berardesca E, Leveque JL, Masson P. EEMCO guidance for the measurement of skin microcirculation. Skin Pharmacol Appl Skin Physiol. 2002;15:442–56.CrossRefPubMed
16.
go back to reference Briers JD. Laser Doppler, speckle and related techniques for blood perfusion mapping and imaging. Physiol Meas. 2001;22:R35–66.CrossRefPubMed Briers JD. Laser Doppler, speckle and related techniques for blood perfusion mapping and imaging. Physiol Meas. 2001;22:R35–66.CrossRefPubMed
17.
go back to reference Mahe G, Humeau-Heurtier A, Durand S, Leftheriotis G, Abraham P. Assessment of skin microvascular function and dysfunction with laser speckle contrast imaging. Circ Cardiovasc Imaging. 2012;5:155–63.CrossRefPubMed Mahe G, Humeau-Heurtier A, Durand S, Leftheriotis G, Abraham P. Assessment of skin microvascular function and dysfunction with laser speckle contrast imaging. Circ Cardiovasc Imaging. 2012;5:155–63.CrossRefPubMed
18.
go back to reference Oberg PA. Laser-Doppler flowmetry. Crit Rev Biomed Eng. 1990;18:125–63.PubMed Oberg PA. Laser-Doppler flowmetry. Crit Rev Biomed Eng. 1990;18:125–63.PubMed
19.
go back to reference Fagrell B. Dynamics of skin microcirculation in humans. J Cardiovasc Pharmacol. 1985;7(Suppl 3):S53–8.CrossRefPubMed Fagrell B. Dynamics of skin microcirculation in humans. J Cardiovasc Pharmacol. 1985;7(Suppl 3):S53–8.CrossRefPubMed
20.
go back to reference Cracowski JL, Minson CT, Salvat-Melis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci. 2006;27:503–8.CrossRefPubMed Cracowski JL, Minson CT, Salvat-Melis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci. 2006;27:503–8.CrossRefPubMed
21.
go back to reference Walther G, Obert P, Fdr Dutheil, Chapier R, Lesourd B, Naughton G, et al. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study. Arterioscler Thromb Vasc Biol. 2015;35:1022–9.CrossRefPubMed Walther G, Obert P, Fdr Dutheil, Chapier R, Lesourd B, Naughton G, et al. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study. Arterioscler Thromb Vasc Biol. 2015;35:1022–9.CrossRefPubMed
22.
go back to reference Beer S, Fo Feihl, Ruiz J, In Juhan-Vague, Aillaud MF, Wetzel SG, et al. Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes. Vasc Health Risk Manag. 2008;4:1449–58.CrossRefPubMedPubMedCentral Beer S, Fo Feihl, Ruiz J, In Juhan-Vague, Aillaud MF, Wetzel SG, et al. Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes. Vasc Health Risk Manag. 2008;4:1449–58.CrossRefPubMedPubMedCentral
23.
go back to reference Roustit M, Cracowski JL. Non-invasive assessment of skin microvascular function in humans: an insight into methods. Microcirculation. 2012;19:47–64.CrossRefPubMed Roustit M, Cracowski JL. Non-invasive assessment of skin microvascular function in humans: an insight into methods. Microcirculation. 2012;19:47–64.CrossRefPubMed
24.
go back to reference Turner J, Belch JJ, Khan F. Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med. 2008;18:109–16.CrossRefPubMed Turner J, Belch JJ, Khan F. Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med. 2008;18:109–16.CrossRefPubMed
25.
go back to reference Wright CI, Kroner CI, Draijer R. Non-invasive methods and stimuli for evaluating the skin’s microcirculation. J Pharmacol Toxicol Methods. 2006;54:1–25.CrossRefPubMed Wright CI, Kroner CI, Draijer R. Non-invasive methods and stimuli for evaluating the skin’s microcirculation. J Pharmacol Toxicol Methods. 2006;54:1–25.CrossRefPubMed
26.
go back to reference Roustit M, Millet C, Blaise S, Dufournet B, Cracowski JL. Excellent reproducibility of laser speckle contrast imaging to assess skin microvascular reactivity. Microvasc Res. 2010;80:505–11.CrossRefPubMed Roustit M, Millet C, Blaise S, Dufournet B, Cracowski JL. Excellent reproducibility of laser speckle contrast imaging to assess skin microvascular reactivity. Microvasc Res. 2010;80:505–11.CrossRefPubMed
27.
go back to reference Stevens MJ, Edmonds ME, Douglas SL, Watkins PJ. Influence of neuropathy on the microvascular response to local heating in the human diabetic foot. Clin Sci (Lond). 1991;80:249–56.CrossRefPubMed Stevens MJ, Edmonds ME, Douglas SL, Watkins PJ. Influence of neuropathy on the microvascular response to local heating in the human diabetic foot. Clin Sci (Lond). 1991;80:249–56.CrossRefPubMed
28.
29.
go back to reference Vongsavan N, Matthews B. Some aspects of the use of laser Doppler flow meters for recording tissue blood flow. Exp Physiol. 1993;78:1–14.CrossRefPubMed Vongsavan N, Matthews B. Some aspects of the use of laser Doppler flow meters for recording tissue blood flow. Exp Physiol. 1993;78:1–14.CrossRefPubMed
30.
go back to reference Kellogg DL Jr, Zhao JL, Wu Y, Johnson JM. Antagonism of soluble guanylyl cyclase attenuates cutaneous vasodilation during whole body heat stress and local warming in humans. J Appl Physiol. 1985;2011(110):1406–13. Kellogg DL Jr, Zhao JL, Wu Y, Johnson JM. Antagonism of soluble guanylyl cyclase attenuates cutaneous vasodilation during whole body heat stress and local warming in humans. J Appl Physiol. 1985;2011(110):1406–13.
32.
go back to reference Minson CT, Berry LT, Joyner MJ. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol. 2001;91:1619–26.PubMed Minson CT, Berry LT, Joyner MJ. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol. 2001;91:1619–26.PubMed
33.
go back to reference Takeshima N, Sozu T, Tajika A, Ogawa Y, Hayasaka Y, Furukawa TA. Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? BMC Med Res Methodol. 2014;14:30.CrossRefPubMedPubMedCentral Takeshima N, Sozu T, Tajika A, Ogawa Y, Hayasaka Y, Furukawa TA. Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? BMC Med Res Methodol. 2014;14:30.CrossRefPubMedPubMedCentral
34.
go back to reference Borenstein M, Hedges L, Higgins J, Rothstein H. Introduction to meta-analysis. New York: Wiley; 2009.CrossRef Borenstein M, Hedges L, Higgins J, Rothstein H. Introduction to meta-analysis. New York: Wiley; 2009.CrossRef
36.
go back to reference Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRefPubMed Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRefPubMed
38.
go back to reference Higgins J, Green S. Cochrane handbook for systematic reviews of interventions, Version 5.1.0: The Cochrane Collaboration; 2011. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions, Version 5.1.0: The Cochrane Collaboration; 2011.
39.
go back to reference Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. 1992;45:769–73.CrossRefPubMed Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. 1992;45:769–73.CrossRefPubMed
40.
go back to reference Abrams KR, Gillies CL, Lambert PC. Meta-analysis of heterogeneously reported trials assessing change from baseline. Stat Med. 2005;24:3823–44.CrossRefPubMed Abrams KR, Gillies CL, Lambert PC. Meta-analysis of heterogeneously reported trials assessing change from baseline. Stat Med. 2005;24:3823–44.CrossRefPubMed
41.
go back to reference Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377–84.CrossRefPubMedPubMedCentral Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377–84.CrossRefPubMedPubMedCentral
42.
go back to reference Aellen J, Dabiri A, Heim A, Liaudet L, Burnier M, Ruiz J, et al. Preserved capillary density of dorsal finger skin in treated hypertensive patients with or without type 2 diabetes. Microcirculation. 2012;19:554–62.CrossRefPubMed Aellen J, Dabiri A, Heim A, Liaudet L, Burnier M, Ruiz J, et al. Preserved capillary density of dorsal finger skin in treated hypertensive patients with or without type 2 diabetes. Microcirculation. 2012;19:554–62.CrossRefPubMed
43.
go back to reference Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia. 1995;38:1337–44.CrossRefPubMed Morris SJ, Shore AC, Tooke JE. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia. 1995;38:1337–44.CrossRefPubMed
44.
go back to reference Petrofsky J, Paluso D, Anderson D, Swan K, Alshammari F, Katrak V, et al. The ability of different areas of the skin to absorb heat from a locally applied heat source: the impact of diabetes. Diabetes Technol Ther. 2011;13:365–72.CrossRefPubMed Petrofsky J, Paluso D, Anderson D, Swan K, Alshammari F, Katrak V, et al. The ability of different areas of the skin to absorb heat from a locally applied heat source: the impact of diabetes. Diabetes Technol Ther. 2011;13:365–72.CrossRefPubMed
45.
go back to reference Petrofsky JS, Alshammari F, Bains GS, Khowailed IA, Lee H, Kuderu YN, et al. What is more damaging to vascular endothelial function: diabetes, age, high BMI, or all of the above? Med Sci Monit. 2013;19:257–63.CrossRefPubMedPubMedCentral Petrofsky JS, Alshammari F, Bains GS, Khowailed IA, Lee H, Kuderu YN, et al. What is more damaging to vascular endothelial function: diabetes, age, high BMI, or all of the above? Med Sci Monit. 2013;19:257–63.CrossRefPubMedPubMedCentral
46.
go back to reference Forst T, Caduff A, Talary M, Weder M, Brandle M, Kann P, et al. Impact of environmental temperature on skin thickness and microvascular blood flow in subjects with and without diabetes. Diabetes Technol Ther. 2006;8:94–101.CrossRefPubMed Forst T, Caduff A, Talary M, Weder M, Brandle M, Kann P, et al. Impact of environmental temperature on skin thickness and microvascular blood flow in subjects with and without diabetes. Diabetes Technol Ther. 2006;8:94–101.CrossRefPubMed
47.
go back to reference Skrha J, Prazny M, Haas T, Kvasnicka J, Kalvodova B. Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in type 1 diabetic patients. J Diabetes Complicat. 2001;15:234–40.CrossRefPubMed Skrha J, Prazny M, Haas T, Kvasnicka J, Kalvodova B. Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in type 1 diabetic patients. J Diabetes Complicat. 2001;15:234–40.CrossRefPubMed
48.
go back to reference Rendell M, Bergman T, O’Donnell G, Drobny E, Borgos J, Bonner RF. Microvascular blood flow, volume, and velocity measured by laser Doppler techniques in IDDM. Diabetes. 1989;38:819–24.CrossRefPubMed Rendell M, Bergman T, O’Donnell G, Drobny E, Borgos J, Bonner RF. Microvascular blood flow, volume, and velocity measured by laser Doppler techniques in IDDM. Diabetes. 1989;38:819–24.CrossRefPubMed
49.
go back to reference Brugler A, Thompson S, Turner S, Ngo B, Rendell M. Skin blood flow abnormalities in diabetic dermopathy. J Am Acad Dermatol. 2011;65:559–63.CrossRefPubMed Brugler A, Thompson S, Turner S, Ngo B, Rendell M. Skin blood flow abnormalities in diabetic dermopathy. J Am Acad Dermatol. 2011;65:559–63.CrossRefPubMed
50.
go back to reference Wigington G, Ngo B, Rendell M. Skin blood flow in diabetic dermopathy. Arch Dermatol. 2004;140:1248–50.CrossRefPubMed Wigington G, Ngo B, Rendell M. Skin blood flow in diabetic dermopathy. Arch Dermatol. 2004;140:1248–50.CrossRefPubMed
51.
go back to reference Ngo B, Wigington G, Hayes K, Huerter C, Hillman B, Adler M, et al. Skin blood flow in necrobiosis lipoidica diabeticorum. Int J Dermatol. 2008;47:354–8.CrossRefPubMed Ngo B, Wigington G, Hayes K, Huerter C, Hillman B, Adler M, et al. Skin blood flow in necrobiosis lipoidica diabeticorum. Int J Dermatol. 2008;47:354–8.CrossRefPubMed
52.
go back to reference Gomes MB, Matheus AS, Tibirica E. Evaluation of microvascular endothelial function in patients with type 1 diabetes using laser-Doppler perfusion monitoring: which method to choose? Microvasc Res. 2008;76:132–3.CrossRefPubMed Gomes MB, Matheus AS, Tibirica E. Evaluation of microvascular endothelial function in patients with type 1 diabetes using laser-Doppler perfusion monitoring: which method to choose? Microvasc Res. 2008;76:132–3.CrossRefPubMed
53.
go back to reference Matheus AS, Tibirica E, da Silva PB, Matta dFBd, Gomes MB. Uric acid levels are associated with microvascular endothelial dysfunction in patients with type 1 diabetes. Diabet Med. 2011;28:1188–93.CrossRefPubMed Matheus AS, Tibirica E, da Silva PB, Matta dFBd, Gomes MB. Uric acid levels are associated with microvascular endothelial dysfunction in patients with type 1 diabetes. Diabet Med. 2011;28:1188–93.CrossRefPubMed
54.
go back to reference Arora S, Smakowski P, Frykberg RG, Simeone LR, Freeman R, LoGerfo FW, et al. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care. 1998;21:1339–44.CrossRefPubMed Arora S, Smakowski P, Frykberg RG, Simeone LR, Freeman R, LoGerfo FW, et al. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care. 1998;21:1339–44.CrossRefPubMed
55.
go back to reference Foster W, Carruthers D, Lip GY, Blann AD. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment. J Rheumatol. 2010;37:711–6.CrossRefPubMed Foster W, Carruthers D, Lip GY, Blann AD. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment. J Rheumatol. 2010;37:711–6.CrossRefPubMed
56.
go back to reference Doupis J, Rahangdale S, Gnardellis C, Pena SE, Malhotra A, Veves A. Effects of diabetes and obesity on vascular reactivity, inflammatory cytokines, and growth factors. Obesity (Silver Spring). 2011;19:729–35.CrossRefPubMed Doupis J, Rahangdale S, Gnardellis C, Pena SE, Malhotra A, Veves A. Effects of diabetes and obesity on vascular reactivity, inflammatory cytokines, and growth factors. Obesity (Silver Spring). 2011;19:729–35.CrossRefPubMed
57.
go back to reference Zomer E, de Ridder I, Kompa A, Komesaroff P, Gilbert R, Krum H. Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension. Clin Exp Pharmacol Physiol. 2008;35:1147–50.CrossRefPubMed Zomer E, de Ridder I, Kompa A, Komesaroff P, Gilbert R, Krum H. Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension. Clin Exp Pharmacol Physiol. 2008;35:1147–50.CrossRefPubMed
58.
go back to reference Economides PA, Caselli A, Tiani E, Khaodhiar L, Horton ES, Veves A. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. J Clin Endocrinol Metab. 2004;89:740–7.CrossRefPubMed Economides PA, Caselli A, Tiani E, Khaodhiar L, Horton ES, Veves A. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. J Clin Endocrinol Metab. 2004;89:740–7.CrossRefPubMed
59.
go back to reference Caselli A, Hanane T, Jane B, Carter S, Khaodhiar L, Veves A. Topical methyl nicotinate-induced skin vasodilation in diabetic neuropathy. J Diabetes Complications. 2003;17:205–10.CrossRefPubMed Caselli A, Hanane T, Jane B, Carter S, Khaodhiar L, Veves A. Topical methyl nicotinate-induced skin vasodilation in diabetic neuropathy. J Diabetes Complications. 2003;17:205–10.CrossRefPubMed
60.
go back to reference Katz A, Ekberg K, Johansson BL, Wahren J. Diminished skin blood flow in type I diabetes: evidence for non-endothelium-dependent dysfunction. Clin Sci (Lond). 2001;101:59–64.CrossRef Katz A, Ekberg K, Johansson BL, Wahren J. Diminished skin blood flow in type I diabetes: evidence for non-endothelium-dependent dysfunction. Clin Sci (Lond). 2001;101:59–64.CrossRef
61.
go back to reference DiMeglio LA, Tosh A, Saha C, Estes M, Mund J, Mead LE, et al. Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae? J Pediatr. 2010;157:540–6.CrossRefPubMedPubMedCentral DiMeglio LA, Tosh A, Saha C, Estes M, Mund J, Mead LE, et al. Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae? J Pediatr. 2010;157:540–6.CrossRefPubMedPubMedCentral
62.
go back to reference Koitka A, Abraham P, Bouhanick B, Sigaudo-Roussel D, Demiot C, Saumet JL. Impaired pressure-induced vasodilation at the foot in young adults with type 1 diabetes. Diabetes. 2004;53:721–5.CrossRefPubMed Koitka A, Abraham P, Bouhanick B, Sigaudo-Roussel D, Demiot C, Saumet JL. Impaired pressure-induced vasodilation at the foot in young adults with type 1 diabetes. Diabetes. 2004;53:721–5.CrossRefPubMed
63.
go back to reference Kilo S, Berghoff M, Hilz M, Freeman R. Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy. Neurology. 2000;54:1246–52.CrossRefPubMed Kilo S, Berghoff M, Hilz M, Freeman R. Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy. Neurology. 2000;54:1246–52.CrossRefPubMed
64.
go back to reference Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care. 1999;22:1865–70.CrossRefPubMed Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care. 1999;22:1865–70.CrossRefPubMed
65.
go back to reference Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care. 2001;24:344–9.CrossRefPubMed Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care. 2001;24:344–9.CrossRefPubMed
66.
go back to reference Shrikhande G, Khaodhiar L, Scali S, Lima C, Hubbard M, Dudley K, et al. Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. J Vasc Surg. 2006;43:760–70.CrossRefPubMed Shrikhande G, Khaodhiar L, Scali S, Lima C, Hubbard M, Dudley K, et al. Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. J Vasc Surg. 2006;43:760–70.CrossRefPubMed
67.
go back to reference Rousseau P, Mahe G, Fromy B, Ducluzeau PH, Saumet JL, Abraham P. Axon-reflex cutaneous vasodilatation is impaired in type 2 diabetic patients receiving chronic low-dose aspirin. Microvasc Res. 2009;78:218–23.CrossRefPubMed Rousseau P, Mahe G, Fromy B, Ducluzeau PH, Saumet JL, Abraham P. Axon-reflex cutaneous vasodilatation is impaired in type 2 diabetic patients receiving chronic low-dose aspirin. Microvasc Res. 2009;78:218–23.CrossRefPubMed
68.
go back to reference Brooks BA, Franjic B, Ban CR, Swaraj K, Yue DK, Celermajer DS, et al. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes Obes Metab. 2008;10:739–46.CrossRefPubMed Brooks BA, Franjic B, Ban CR, Swaraj K, Yue DK, Celermajer DS, et al. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes Obes Metab. 2008;10:739–46.CrossRefPubMed
69.
go back to reference Brooks BA, McLennan SV, Twigg SM, Yue DK. Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications. Diab Vasc Dis Res. 2008;5:30–5.CrossRefPubMed Brooks BA, McLennan SV, Twigg SM, Yue DK. Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications. Diab Vasc Dis Res. 2008;5:30–5.CrossRefPubMed
70.
go back to reference Economides PA, Caselli A, Zuo CS, Sparks C, Khaodhiar L, Katsilambros N, et al. Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism. 2004;53:222–7.CrossRefPubMed Economides PA, Caselli A, Zuo CS, Sparks C, Khaodhiar L, Katsilambros N, et al. Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism. 2004;53:222–7.CrossRefPubMed
71.
go back to reference Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34:3035–87.CrossRefPubMed Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34:3035–87.CrossRefPubMed
72.
go back to reference Charkoudian N. Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. Mayo Clin Proc. 2003;78:603–12.CrossRefPubMed Charkoudian N. Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. Mayo Clin Proc. 2003;78:603–12.CrossRefPubMed
73.
go back to reference Stirban A. Microvascular dysfunction in the context of diabetic neuropathy. Curr DiabRep. 2014;14:541.CrossRef Stirban A. Microvascular dysfunction in the context of diabetic neuropathy. Curr DiabRep. 2014;14:541.CrossRef
74.
go back to reference Östlund Papadogeorgos N, Jörneskog G, Bengtsson M, Kahan T, Kalani M. Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome. Cardiovasc Diabetol. 2016;15:66.CrossRefPubMedPubMedCentral Östlund Papadogeorgos N, Jörneskog G, Bengtsson M, Kahan T, Kalani M. Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome. Cardiovasc Diabetol. 2016;15:66.CrossRefPubMedPubMedCentral
75.
go back to reference Tomešová J, Gruberova J, Lacigova S, Cechurova D, Jankovec Z, Rusavy Z. Differences in skin microcirculation on the upper and lower extremities in patients with diabetes mellitus: relationship of diabetic neuropathy and skin microcirculation. Diabetes Technol Ther. 2013;15:968–75.CrossRefPubMed Tomešová J, Gruberova J, Lacigova S, Cechurova D, Jankovec Z, Rusavy Z. Differences in skin microcirculation on the upper and lower extremities in patients with diabetes mellitus: relationship of diabetic neuropathy and skin microcirculation. Diabetes Technol Ther. 2013;15:968–75.CrossRefPubMed
76.
go back to reference Taub PR, Higginbotham E, Henry RR. Beneficial and detrimental effects of glycemic control on cardiovascular disease in type 2 diabetes. Curr Cardiol Rep. 2013;15:332.CrossRefPubMed Taub PR, Higginbotham E, Henry RR. Beneficial and detrimental effects of glycemic control on cardiovascular disease in type 2 diabetes. Curr Cardiol Rep. 2013;15:332.CrossRefPubMed
77.
go back to reference Blonde L. Benefits and risks for intensive glycemic control in patients with diabetes mellitus. Am J Med Sci. 2012;343:17–20.CrossRefPubMed Blonde L. Benefits and risks for intensive glycemic control in patients with diabetes mellitus. Am J Med Sci. 2012;343:17–20.CrossRefPubMed
78.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–12.CrossRefPubMed Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–12.CrossRefPubMed
Metadata
Title
The association between diabetes and dermal microvascular dysfunction non-invasively assessed by laser Doppler with local thermal hyperemia: a systematic review with meta-analysis
Authors
Dagmar Fuchs
Pepijn P. Dupon
Laura A. Schaap
Richard Draijer
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2017
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-016-0487-1

Other articles of this Issue 1/2017

Cardiovascular Diabetology 1/2017 Go to the issue